TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock-Reference-Cited by-同舟云学术

TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock

Published:2007-10-18 Issue:9 Volume:179 Page:6107-6114
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Daubeuf Bruno,Mathison John,Spiller Stephan,Hugues Stephanie,Herren Suzanne,Ferlin Walter,Kosco-Vilbois Marie,Wagner Hermann,Kirschning Carsten J.,Ulevitch Richard,Elson Greg

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

2. Sepsis and evolution of the innate immune response

3. The immunopathogenesis of sepsis

4. The Pathophysiology and Treatment of Sepsis

5. A family of human receptors structurally related to Drosophila Toll

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like Receptor 4 in Acute Kidney Injury;International Journal of Molecular Sciences;2023-01-11

2. CD14 blockade to prevent ischemic injury to donor organs;Transplant Immunology;2022-06

3. Sex differences in TLR4 expression in SHR do not contribute to sex differences in blood pressure or the renal T cell profile;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2022-04-01

4. Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective;Genes & Diseases;2022-02

5. Therapeutic regimens of endotoxaemia in sheep;BULGARIAN JOURNAL OF VETERINARY MEDICINE;2022